BlackRock Institutional Trust’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $15.4M | Buy |
2,620,238
+31,625
| +1% | +$185K | ﹤0.01% | 2150 |
|
|
2016
Q3 | $13.7M | Buy |
2,588,613
+175,601
| +7% | +$932K | ﹤0.01% | 2132 |
|
|
2016
Q2 | $16M | Sell |
2,413,012
-214,462
| -8% | -$1.42M | ﹤0.01% | 1991 |
|
|
2016
Q1 | $12.3M | Buy |
2,627,474
+4,057
| +0.2% | +$18.9K | ﹤0.01% | 2129 |
|
|
2015
Q4 | $13.2M | Buy |
2,623,417
+76,006
| +3% | +$384K | ﹤0.01% | 2138 |
|
|
2015
Q3 | $8.97M | Buy |
2,547,411
+60,599
| +2% | +$213K | ﹤0.01% | 2362 |
|
|
2015
Q2 | $24.8M | Sell |
2,486,812
-125,582
| -5% | -$1.25M | ﹤0.01% | 1771 |
|
|
2015
Q1 | $33.3M | Buy |
2,612,394
+193,055
| +8% | +$2.46M | 0.01% | 1589 |
|
|
2014
Q4 | $34.2M | Sell |
2,419,339
-121,588
| -5% | -$1.72M | 0.01% | 1550 |
|
|
2014
Q3 | $34.9M | Sell |
2,540,927
-13,084
| -0.5% | -$180K | 0.01% | 1504 |
|
|
2014
Q2 | $39.3M | Sell |
2,554,011
-6,449
| -0.3% | -$99.2K | 0.01% | 1487 |
|
|
2014
Q1 | $43.6M | Buy |
2,560,460
+166,953
| +7% | +$2.84M | 0.01% | 1386 |
|
|
2013
Q4 | $31M | Sell |
2,393,507
-40,958
| -2% | -$530K | 0.01% | 1605 |
|
|
2013
Q3 | $24.6M | Buy |
2,434,465
+150,572
| +7% | +$1.52M | ﹤0.01% | 1707 |
|
|
2013
Q2 | $17.1M | Buy |
+2,283,893
| New | +$17.1M | ﹤0.01% | 1924 |
|